Janux Therapeutics, Inc.
← Back to JANX Overview

Janux Therapeutics, Inc. (JANX)

Profitability & Net Margin History

Current Net Margin

-405.41%

Janux Therapeutics, Inc. currently has a net profit margin of -405.41%.

Financial Fundamentals

JANXQuarterly Data • 5Y View

Historical Margin Data

DateRev ($B)NI ($B)Net MarginChange (bps)
2025-12-310.01-0.03-405.41%16228
2025-09-300.01-0.02-243.13%
2025-06-300.00-0.03
2025-03-310.00-0.02
2024-12-310.00-0.02
2024-09-300.00-0.03-6391.57%632459
2024-06-300.01-0.01-66.98%111194
2024-03-310.00-0.01-1178.91%70114
2023-12-310.00-0.01-477.77%1818
2023-09-300.00-0.01-459.59%119679
2023-06-300.00-0.02-1656.39%80390
2023-03-310.00-0.02-852.49%28782
2022-12-310.00-0.02-564.67%35623
2022-09-300.00-0.02-920.90%20682
2022-06-300.00-0.02-714.08%12985
2022-03-310.00-0.01-843.93%1373
2021-12-310.00-0.01-830.20%9871
2021-09-300.00-0.01-928.90%35865
2021-06-300.00-0.01-1287.55%68650
2021-03-310.00-0.00-601.05%
2020-12-310.00-0.00
2020-09-300.00-0.00
2020-06-300.00-0.00
2020-03-310.00-0.00

* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.